Sartorius AG Stock
Stocks
SRT3
DE0007165631
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Xetra
20:36:22 06/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 290.00 EUR | +0.87% |
|
-0.62% | +17.31% |
| 10-29 | Sartorius AG : Downgraded from Neutral to Sell by DZ Bank | ZD |
| 10-29 | DZ Bank cuts Sartorius to 'Sell' - fair value €225 | DP |
| Market Cap | 17.86B 19.92B 16.33B 14.9B 28.08B 1,872B 28.96B 197B 78.47B 999B 74.76B 73.16B 3,154B | P/E 2026 * |
76x | P/E 2027 * | 58.6x |
|---|---|---|---|---|---|
| Enterprise Value | 21.44B 23.91B 19.6B 17.89B 33.7B 2,247B 34.77B 236B 94.19B 1,199B 89.73B 87.81B 3,785B | EV / Sales 2026 * |
5.74x | EV / Sales 2027 * | 5.14x |
| Free-Float |
35.87% | Yield 2026 * |
0.27% | Yield 2027 * | 0.33% |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| SRT3 | Delayed | |
CBOE
| SRT3d | Real-time | |
|
Tradegate
| SRT3 | Real-time | |
|
CBOE
| 0NIR | Real-time | |
|
Boerse Muenchen
| SRT3 | Real-time | |
|
Börse Stuttgart
| SRT3 | Delayed | |
|
London S.E.
| 0NIR | Delayed | |
|
Bulgaria S.E.
| SRT3 | End-of-day quote | |
|
OTC Markets
| SUVPF | Delayed | |
|
Deutsche Boerse AG
| SRT3 | Delayed | |
|
Swiss Exchange
| SRT3 | Delayed | |
|
Wiener Boerse
| SRT3 | End-of-day quote | |
|
Borsa Italiana
| 1SRT3 | End-of-day quote |
Last Transcript: Sartorius AG
| 1 day | +0.87% | ||
| 1 week | -0.62% | ||
| Current month | -0.62% | ||
| 1 month | +11.67% | ||
| 3 months | +26.36% | ||
| 6 months | +29.87% | ||
| Current year | +17.31% |
| 1 week | 280 |  | 298.8 |
| 1 month | 244.1 | | 299.3 |
| Current year | 198.5 | | 299.3 |
| 1 year | 198.5 | | 299.3 |
| 3 years | 166.05 | | 383.7 |
| 5 years | 166.05 | | 631.6 |
| 10 years | 63.65 | | 631.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Grosse
CEO | Chief Executive Officer | 59 | 30/06/2025 |
Florian Funck
DFI | Director of Finance/CFO | 55 | 01/04/2024 |
Volker Niebel
COO | Chief Operating Officer | 70 | 01/01/2001 |
| Director | Title | Age | Since |
|---|---|---|---|
Annette Becker
BRD | Director/Board Member | 62 | 01/09/2002 |
Lothar Kappich
CHM | Chairman | 69 | 19/07/2017 |
| Director/Board Member | 77 | 29/11/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/05/26 | Free | Executive/Senior Manager | 4,268 | 0.0114% | ||
| 01/05/26 | Free | Executive/Senior Manager | 5,203 | 0.0139% | ||
| 12/03/26 | Buy | Chairman | 191 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.87% | -0.62% | +29.81% | +15.22% | 19.95B | |
| +2.63% | -0.32% | +22.75% | +52.69% | 251B | |
| -3.36% | +4.81% | -17.34% | +63.31% | 162B | |
| +1.73% | -0.85% | +9.29% | +17.76% | 159B | |
| -4.23% | +1.83% | -56.84% | -19.05% | 64.7B | |
| +1.31% | +11.01% | +23.90% | +52.22% | 57.97B | |
| -0.76% | +4.13% | +0.84% | -6.12% | 56.21B | |
| -2.05% | -2.95% | +4.30% | +54.85% | 50.21B | |
| +1.73% | -0.06% | +18.49% | +62.52% | 48.43B | |
| +1.00% | -1.11% | +23.29% | +81.48% | 44.51B | |
| Average | -0.11% | +0.93% | +5.85% | +37.49% | 91.45B | |
| Weighted average by Cap. | +0.21% | +1.18% | +5.32% | +41.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.73B 4.16B 3.41B 3.12B 5.87B 391B 6.06B 41.14B 16.41B 209B 15.63B 15.29B 659B | 4.11B 4.58B 3.76B 3.43B 6.46B 431B 6.66B 45.27B 18.05B 230B 17.2B 16.83B 726B |
| Net income | 259M 289M 237M 216M 408M 27.19B 421M 2.86B 1.14B 14.51B 1.09B 1.06B 45.8B | 335M 373M 306M 279M 526M 35.06B 542M 3.69B 1.47B 18.71B 1.4B 1.37B 59.06B |
| Net Debt | 3.58B 3.99B 3.27B 2.98B 5.62B 375B 5.8B 39.41B 15.71B 200B 14.97B 14.65B 632B | 3.27B 3.65B 2.99B 2.73B 5.14B 343B 5.3B 36.04B 14.37B 183B 13.69B 13.4B 578B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | €290.00 | +0.87% | 109,149 |
| 05/11/26 | €287.50 | -0.35% | 98,910 |
| 04/11/26 | €288.50 | -1.43% | 91,692 |
| 03/11/26 | €292.70 | -1.41% | 103,102 |
| 02/11/26 | €296.90 | +1.75% | 94,787 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SRT3 Stock
Select your edition
All financial news and data tailored to specific country editions
